share_log

Lake Street Maintains Buy on Biolase, Lowers Price Target to $0.4

Lake Street Maintains Buy on Biolase, Lowers Price Target to $0.4

Lake Street维持对Biolase的买入,将目标股价下调至0.4美元
Benzinga ·  2023/05/31 09:28

Lake Street analyst Frank Takkinen maintains Biolase (NASDAQ:BIOL) with a Buy and lowers the price target from $1.5 to $0.4.

湖街分析师弗兰克·塔基宁维持Biolase(纳斯达克股票代码:BIOL)的买入,并将目标股价从1.5美元下调至0.4美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发